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Summary The mechanism of tumour necrosis photosensitised by liposome-delivered Zn(II) phthalocyanine
(Zn-Pc) has been studied in mice bearing a transplanted MS-2 fibrosarcoma. Ultrastructural analyses of
tumour specimens obtained at different times after red light-irradiation (300 J cm-2, dose-rate 180 mW cm-2)
indicate an early (3 h) photodamage of malignant cells especially at the level of the mitochondria and rough
endoplasmic reticulum. The cellular damage becomes more evident between 6 h and 15 h after photodynamic
therapy. On the other hand, the capillaries supplying the tumour tissue are modified at a much slower rate and
appear to be severely damaged only after 15 h from irradiation, when the whole tissue becomes necrotic.
Occasionally, mildly damaged capillaries are observed even at 72 h after irradiation. These findings support the
hypothesis that low density lipoproteins (LDL) play a major role in the delivery of Zn-Pc to the tumour tissue;
the photosensitiser is released specifically to malignant cells as a consequence of a receptor-mediated
endocytosis of LDL.
Previous studies from our laboratory (Reddi et al., 1990)
indicate that liposome-delivered Zn(II)-phthalocyanine (Zn-
Pc) is a promising candidate to replace HpD or its active
components in the photodynamic therapy (PDT) of tumours.
In the case of mice bearing an MS-2 fibrosarcoma that
received 0.12 mg kg-' Zn-Pc, PDT treatment generates a
tumour necrosis whose extent is at least as large as that
obtained after injection of 5 mg kg-' HpD. The observed
quantitative release of the Zn-Pc from the liposome vesicles
to serum lipoproteins ensures a more homogeneous transport
of the photosensitising agent in the bloodstream, as well as
its efficient accumulation and retention by neoplastic tissues
of experimental animals. This fact should be important for
the definition of suitable phototherapeutic protocols which
are based on the actual concentration of the drug in the
tumour tissue at the moment in which PDT is performed
(Jori, 1987).
Towards this aim, it is also necessary to obtain a detailed
description of the mechanisms involved in the Zn-Pc-
photosensitised destruction of tumour tissues subjected to
PDT. As a first step in this direction, we have performed
ultrastructural studies on tumour samples obtained from
mice bearing an MS-2 fibrosarcoma at various times after the
PDT treatment in the presence of Zn-Pc. Previous investiga-
tions showed that this technique can provide useful inform-
ation as regards the progress of tissue necrosis in tumours
which have undergone PDT after administration of HpD
(Bellnier & Lin, 1984; Zhou et al., 1988a) and haematopor-
phyrin (Zhou et al., 1988b).
Materials and methods
The procedures adopted for the incorporation of Zn-Pc into
small unilamellar liposomes of DPPC, its i.v. injection to
Balb/c mice bearing a transplanted MS-2 fibrosarcoma in the
right hind leg, and the irradiation of the tumour area with
red light were the same as previously described (Reddi et al.,
1990).
In the experiments described in the present paper, the mice
having a tumour with an external diameter equal to
0.6-0.7cm received a Zn-Pc dose of 0.12mg kg-' body
weight. At 24 h after injection, the tumour area was depilated
and exposed to 300 J cm-2 of 590-740 nm light at a dose-
rate of 180 mW cm-2.
The mice were killed at 3, 6, 15, 24, 48 and 72 h after the
end of the phototherapeutic treatment (three mice at each
time) by exposure to vapours of diethyl ether. Small pieces of
macroscopically non-necrotised tumour tissue were quickly
removed. The specimens were fixed in 3% glutaraldehyde,
0.1 M cacodylate - buffered at pH 7.3, for 2 h at 4°C, post-
fixed in 1% OS04 cacodylate - buffered for 1 h, dehydrated
and embedded in Epon. The thin sections were doubly
stained with uranyl acetate and lead citrate and then
examined with a Philips EM-410 TEM and Hitachi H-600
TEM.
Control mice were represented by mice that were subjected
to the above described PDT treatment in the absence of
Zn-Pc. Previous studies (Milanesi et al., 1987) had shown
that the administration of liposome-bound Zn-Pc
(0.5mgkg-') causes no detectable ultrastructural alterations
of the MS-2 fibrosarcoma in mice.
Results
The tumours of unirradiated Balb/c mice were composed by
densely arranged cells of polygonal or slightly elongated
shape (Figure la). The nucleus is often rather large and
contains a prominent nucleolus. The cytoplasm is charac-
terised by the presence of somewhat scattered mitochondria
with less frequent cristae, as is typical of several types of
malignant cells (Pedersen, 1978), abundant free ribosomes, a
few profiles of rough endoplasmic reticulum, and sometimes
Golgi complex. The capillaries in the tumour tissue (Figure
b) appear to be of continuous type and are composed by a
very thin layer of endothelial cells. The ultrastructural
features of tumours isolated from mice that had been
irradiated in the absence of Zn-Pc are essentially identical
with those observed for untreated mice. This suggests that
irradiation alone exerts no tissue-damaging effects, at least
under our experimental conditions.
At 3 h after PDT in the presence of liposome-delivered
Zn-Pc the capillaries supplying the tumour tissue appear to
be very well preserved (Figure 2a and b) being almost iden-
tical with those seen in the control mice. The congestion of
the capillaries by erythrocytes may reflect an early dilation of
vessels in the irradiated tumour (Star et al., 1986). On the
other hand, as one can observe in Figure 2, some malignant
cells display some vacuolisation and markedly swollen and
empty mitochondria, indicating that PDT induced an early
degeneration of these compartments of malignant cells. The
damage at the level of the malignant cells becomes even more
evident at 6 h after irradiation (Figure 3): several tumour
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Figure 1 a, Tumour cells of a control mouse are polygonal, with
a large nucleus (N), mitochondria (m), abundant free ribosomes,
profiles of rough endoplasmic reticulum (RER) and Golgi com-
plex (G). x 9,000. b, Blood vessels in tumoral tissue are of
continuous type. L = lumen; N = nucleus; E = endothelium.
x 15,000.
cells actually appear degenerative with largely swollen and
sometime disrupted mitochondria and considerably dilated
rough endoplasmic reticulum (Figure 3a).
Some individual cells are already necrotised and destroyed.
On the contrary, the capillary endothelial cells (Figure 3b)
continue to be well preserved, only minimal changes being
observed in their cytoplasm. It is important to underline that
closely similar ultrastructural data were obtained with
different tissue specimens taken from different animal.
Figure 2 Typical micrographs obtained 3 h after PDT. a, The
capillary supplying tumour cells is very well preserved; tumour
cells contain some vacuolisation (v) and swollen mitochondria
(arrows). x9,000. b, Higher magnification shows more clearly
that endothelial cells are much better preserved than neoplastic
cells. x 17,000.
Therefore, the results illustrated in Figures 1-3 (as well as in
the subsequent figures) appear to be of general validity.
Only at 15 h after PDT (Figure 4) does the photoinduced
necrotic process begin to involve the whole tumour tissue.
The micrographs show a widespread occurrence of necrotised
and disintegrated neoplastic cells, although some relatively
more resistant cells are occasionally observed (see the tumour
cell T adjacent to the erythrocytes in Figure 5). Moreover,
some severely damaged capillaries with swollen or disrupted
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Figure 4 Fifteen hours after PDT, photoinduced damage
involves both malignant and endothelial cells. Micrograph shows
widespread degeneration of the tumoral tissue. E = endothelium;
N = nucleus; RC = red blood cells. x 12,000.
Figure 3 Typical micrographs obtained 6 h after PDT. a, Several
tumour cells appear degenerative, with swollen mitochondria and
dilated profiles of rough endoplasmic reticulum (arrows).
x 12,000. b, Blood vessels are well preserved. N = endothelial
nucleus; T = tumour cell. x 15,000.
mitochondria and a dilated endoplasmic reticulum are
detected (Figure 4). At 24 h after irradiation, the tumour
tissue is almost entirely necrotic and no viable-appearing
tumour cells could be observed in any of the specimens taken
up to 72 h. Occasionally, rather mildly damaged capillaries
surrounded by completely necrotic tumour cells are detected
even at 72 h after PDT (Figure 6).
In a few experiments, the tumour-bearing mice were i.v.
injected with 0.12 mg kg-' Zn-Pc associated with human
LDL. Upon irradiation of the tumour tissue we observed
ultrastructural changes identical with those found in the case
of mice that had received liposome-bound Zn-Pc.
Figure 5 Tumour tissue is completely necrotic 24 h after PDT.
T = tumour cell. x 8,500.MECHANISM OF PDT-INDUCED TUMOUR NECROSIS 849
Figure 6 A mildly damaged capillary, surrounded by completely
necrotic tumour, is occasionally detected even 72 h after PDT.
x 7,000.
Discussion
Our ultrastructural studies with a PDT-treated experimental
tumour further support the conclusion (Reddi et al., 1990)
that Zn-Pc is a very efficient phototherapeutic agent.
Extensive necrotic degeneration of the tumour tissues is
obtained upon administration of 0.12 mg kg-' Zn-Pc, i.e. a
dose at least 20-fold lower than that presently used for
clinical PDT in the presence of HpD or Photofrin II
(Dougherty, 1987). In particular, the electron microscopy
data clearly indicate that the mechanism by which Zn-Pc
induces the necrosis of irradiated tumours is remarkably
different from that observed after PDT of tumours loaded
with HpD (Henderson et al., 1985; Star et al., 1986; Chopp
et al., 1987) or water-soluble phthalocyanines, such as
aluminum tetrasulphophthalocyanine (Selman et al., 1986).
With all these photosensitisers the tissue photodamage
primarily involves the blood vessels, while the photodamage
of the malignant cells either occurs at a slower rate or is an
indirect consequence of the vascular damage. In contrast, for
irradiations in the presence of Zn-Pc, the neoplastic cells
clearly represent the initial direct target of PDT, and the
capillaries in the tumour tissue are modified at later stage
and to a less severe extent. Indeed, upon both gross inspec-
tion and microscopic examination, we found only low levels
of haemorrhage in the necrotic tumours: haemorrhagic
necrosis is very frequently observed during PDT with HpD.
We ascribe the different mechanism of tumour necrosis
observed for PDT with Zn-Pc to the modality of transport
and delivery of this drug to tumours. As discussed in a
previous paper (Reddi et al., 1990), Zn-Pc is selectively car-
ried by serum lipoproteins, and hence it is likely that its
release to malignant cells through receptor-mediated endo-
cytosis of LDL plays an important role owing to the elevated
number of LDL-receptors associated with neoplastic cells
(Gal et al., 1981).
This would explain the identity between the ultrastructural
modifications detected after administration of liposome-
bound or LDL-bound Zn-Pc. By this process, the photosen-
sitising agent is specifically delivered to malignant cells and
localises in the cellular membranes (Brown et al., 1980; Can-
dide et al., 1986). On the other hand, more polar photosen-
sitisers, which can be injected as a homogeneous aqueous
solution, are largely transported by albumin and other serum
proteins and localise mainly in the vascular stroma (Kessel et
al., 1987).
The proposed sequence of events is in agreement with the
pattern of ultrastructural changes observed in our experi-
mental tumour, namely the early alteration of the mito-
chondria and the cytoplasmic membrane of malignant cells.
Moreover, we have previously shown (Zhou et al., 1988a)
that liposome- or LDL-delivered haematoporphyrin causes
minimal degree of PDT-induced vascular damage and a
direct photosensitisation of tumour cells, whereas the
opposite situation takes place upon injection of aqueous
haematoporphyrin. Therefore, it is likely that the mechanism
of photoinduced tumour necrosis observed in the case of
Zn-Pc is not a unique property of the dye, but is a conse-
quence of the transport mechanism. Of course, more detailed
experimental studies are to be performed in order to cor-
roborate our hypothesis. In any case, the results described in
this paper open two interesting prospects.
1. The possibility of achieving the specific delivery to
tumour cells in vivo of any hydrophobic photosensitiser
which can be incorporated into liposomal vesicles or LDL.
This would yield a large flexibility in the choice of the
phototherapeutic agent, whose spectroscopic and photosen-
sitising properties could be tailored to the optical features
and biochemical or physiological characteristics of the
tumour to be irradiated. In fact, we have recently obtained a
selective accumulation of other liposome-bound dyes, such as
porphycenes and naphthalocyanines, by experimental
tumours.
2. The continuation of oxygen supply to tumours for some
hours after PDT. This circumstance may potentiate the PDT-
induced damage which is known to be of oxidative nature
(Lee See et al., 1984) by reducing the hypoxic areas with only
partially modified neoplastic cells (Freitas, 1985), similar to
what is often observed to occur in the radiotherapy of
tumours (Moulder & Rockwell, 1984). Such areas are more
likely to be formed as a consequence of vascular damage and
are a common origin of tumour recurrences.
References
BELLNIER, D.A. & LIN, C.W. (1984). Giant cell formation in bladder
tumor cells following hematoporphyrin derivative-sensitized
photoirradiation. Photochem. Photobiol., 39, 425.
BROWN, M.S., KOVANEN, P.T. & GOLDSTEIN, J.L. (1980). Evolution
of the LDL receptor concept from cultured animal cells to intact
animals. Proc. NY Acad. Sci., 348, 48.
CANDIDE, C., MORLIERE, P., MAZIERE, J.C. & 5 others (1986). In
vitro interaction of the photoactive anticancer porphyrin
derivative photofrin II with low density lipoprotein and its
delivery to cultered human fibroblasts. FEBS Lett., 33, 183.
CHOPP, M., GLASBERG, M.R., RIDDLE, J.M., HETZEL, F.W. &
WELCH, K.M.A. (1987). Photodynamic therapy of normal cere-
bral tissue in the cat: a non-invasive model for cerebrovascular
thrombosis. Photochem. Photobiol., 46, 103.
DOUGHERTY, T.J. (1987). Photosensitizers: therapy and detection of
malignant tumors. Photochem. Photobiol., 45, 879.
FREITAS, 1. (1985). Role of hypoxia in photodynamic therapy of
tumors. Tumori, 71, 251.850 C. MILANESI et at.
GAL, D., MCDONALD, P.C., PORTER, J.C. & SIMPSON, E.R. (1981).
Cholesterol metabolism in cancer cells in monolayer culture. III.
Low-density lipoprotein metabolism. Int. J. Cancer, 29, 315.
HENDERSON, B.W., WALDOW, S.M. & MANG, T.S. (1985). Tumor
destruction and kinetics of tumor cell death in two experimental
mouse tumors following photodynamic therapy. Cancer Res., 45,
572.
JORI, G. (1987). Photodynamic therapy of solid tumors. Radiat.
Phys. Chem., 30, 375.
KESSEL, D., THOMPSON, P., SOATIO, K. & NANTURI, K.D. (1987).
Tumor localization and photosensitization by sulfonated
derivatives of tetraphenylporphine. Photochem. Photobiol., 45,
787.
LEE SEE, K., FORBES, I.J. & BETTS, W.H. (1984). Oxygen dependency
of phototoxicity with hematoporphyrin derivative. Photochem.
Photobiol., 39, 631.
MILANESI, C., BIOLO, R., REDDI, E. & JORI, G. (1987). Ultrastruc-
tural studies on the mechanism of the photodynamic therapy of
tumors. Photochem. Photobiol., 46, 675.
MOULDER, J. & ROCKWELL, S. (1984). Hypoxic fractions of solid
tumors: experimental techniques, methods of analysis, and a
survey ofexisting data. Int. J. Radiat. Oncol. Biol. Phys., 10, 695.
PEDERSEN, F.L. (1978). Tumor mitochondria and the bioenergetics
of cancer cells. Prog. Exp. Tumor Res., 22, 190.
REDDI, E., ZHOU, C., BIOLO, R., MENEGALDO, E. & JORI, G. (1990).
Zn(II)-phthalocyanine as a photodynamic agent for tumours. I.
Pharmacokinetic properties and phototherapeutic efficiency. Br.
J. Cancer (in the press).
SELMAN, S.H., KREIMER-BIRNBAUM, M., CHADHURI, K. & 5 others
(1986). Photodynamic treatment of transplantable bladder tumors
in rodents after pretreatment with chloroaluminum tetrasulfo-
phthalocyanine. J. Urol., 136, 141.
STAR, W.M., MARIJNISSEN, H.P.A., VAN DEN BERG-BLOK, A.E.,
VERSTEEG, J.A., FRANKEN, K.A. & REINHOLD, H.S. (1986). De-
struction of rat mammary tumor and normal tissue microcircula-
tion by hematoporphyrin derivate. Photoradiation observed in
sandwich observation chambers. Cancer Res., 46, 2532.
ZHOU, C.N., XU, B.J., XIE, J.G. & 6 others (1988a). An ultrastructural
study of human bladder cancer treated with photodynamic
therapy. Lasers Med. Sci., 3, 87.
ZHOU, C.N., MILANESI, C. & JORI, G. (1988b). An ultrastructural
comparative evaluation of tumors photosensitized by porphyrins
administered in aqueous solution, bound to liposomes or to
lipoproteins. Photochem. Photobiol., 48, 487.